These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29658472)

  • 41. Neonatal screening for sickle cell disorders in Ouagadougou, Burkina Faso: a pilot study.
    Kafando E; Sawadogo M; Cotton F; Vertongen F; Gulbis B
    J Med Screen; 2005; 12(3):112-4. PubMed ID: 16156939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trends in sickle cell trait and disease screening in the Republic of Uganda, 2014-2019.
    Hernandez AG; Kiyaga C; Howard TA; Ssewanyana I; Ndeezi G; Aceng JR; Ware RE
    Trop Med Int Health; 2021 Jan; 26(1):23-32. PubMed ID: 33151598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Newborn screening for sickle cell anemia].
    Dulín-Iñiguez E
    Med Clin (Barc); 2006 Mar; 126(8):293-4. PubMed ID: 16527156
    [No Abstract]   [Full Text] [Related]  

  • 44. Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research.
    Davies SC; Cronin E; Gill M; Greengross P; Hickman M; Normand C
    Health Technol Assess; 2000; 4(3):i-v, 1-99. PubMed ID: 10840658
    [No Abstract]   [Full Text] [Related]  

  • 45. Sickle cell disease from Africa to Belgium, from neonatal screening to clinical management.
    Lê PQ; Ferster A; Cotton F; Vertongen F; Vermylen C; Vanderfaeillie A; Dedeken L; Heijmans C; Ketelslegers O; Dresse MF; Gulbis B
    Med Trop (Mars); 2010 Dec; 70(5-6):467-70. PubMed ID: 21516988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Newborn screening for sickle cell disease: whose reproductive benefit?
    Ross LF
    Eur J Hum Genet; 2012 May; 20(5):484-5. PubMed ID: 22071892
    [No Abstract]   [Full Text] [Related]  

  • 47. Prevalence of sickle cell disease among Grenadian newborns.
    Antoine M; Lee K; Donald T; Belfon Y; Drigo A; Polson S; Martin F; Mitchell G; Etienne-Julan M; Hardy-Dessources MD
    J Med Screen; 2018 Mar; 25(1):49-50. PubMed ID: 29183229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Neonatal detection of sickle cell disease in metropolitan France. Association française pour le dépistage et la prévention des handicaps de l'enfant (AFDPHE)].
    Galactéros F
    Arch Pediatr; 1996 Oct; 3(10):1026-31. PubMed ID: 8952800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Newborn screening for sickle cell disease in sub-Saharan Africa: Is the glass half-full yet?
    Smart LR; Ware RE
    Pediatr Blood Cancer; 2021 Jul; 68(7):e29137. PubMed ID: 34019327
    [No Abstract]   [Full Text] [Related]  

  • 50. [Economic analysis of neonatal screening for drepanocytosis in metropolitan France].
    Le Galès C; Galactéros F
    Rev Epidemiol Sante Publique; 1994; 42(6):478-92. PubMed ID: 7816961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Managing sickle cell carrier results generated through newborn screening in Ontario: a precedent-setting policy story.
    Hayeems RZ; Moore Hepburn C; Chakraborty P; Odame I; Clarke J; Miller FA; Brown AD
    Genet Med; 2017 Jun; 19(6):625-627. PubMed ID: 27763632
    [No Abstract]   [Full Text] [Related]  

  • 52. Sickle cell disease in childhood: from newborn screening through transition to adult medical care.
    Quinn CT
    Pediatr Clin North Am; 2013 Dec; 60(6):1363-81. PubMed ID: 24237976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term follow-up of children with sickle cell disease diagnosed by newborn screening in the Netherlands: Overview of morbidity and mortality.
    Vuong C; Eckhardt CL; Heijboer H; Suijker MH; de Ligt LA; Voigt ALA; Leeflang MMG; Bartels M; Brons P; Hooimeijer L; Rettenbacher E; Smiers FJ; Stein-Wit MA; van der Veer A; Verbaan A; Cnossen MH; Fijnvandraat K
    Am J Hematol; 2024 Aug; 99(8):1606-1609. PubMed ID: 38682156
    [No Abstract]   [Full Text] [Related]  

  • 54. Screening for haemoglobin disorders: One size may not fit all.
    Shook LM; Ware RE
    Br J Haematol; 2024 Jan; 204(1):26-28. PubMed ID: 37877454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening for sickle cell disease in newborns.
    Lin KW
    Am Fam Physician; 2009 Mar; 79(6):507-8. PubMed ID: 19323364
    [No Abstract]   [Full Text] [Related]  

  • 56. Sickle cell disease in North Europe.
    Howard J; Davies SC
    Scand J Clin Lab Invest; 2007; 67(1):27-38. PubMed ID: 17365983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness of neonatal screening for sickle cell disease.
    Lane PA; Eckman JR
    J Pediatr; 1992 Jan; 120(1):162-3. PubMed ID: 1731017
    [No Abstract]   [Full Text] [Related]  

  • 58. [Acceptability of neonatal screening of the sickle cell disease during the pandemic of COVID-19 in Kisangani, Democratic Republic of the Congo].
    Kasai ET; Opara JPAA; Agasa SB; Gulbis B; Uvoya NA; Nguma JDB; Maloba PK; Hubert P; Etienne AM; Djang Eing A RM
    Pan Afr Med J; 2020; 37():299. PubMed ID: 33654518
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sickle-cell disease not identified by newborn screening because of prior transfusion.
    Reed W; Lane PA; Lorey F; Bojanowski J; Glass M; Louie RR; Lubin BH; Vichinsky EP
    J Pediatr; 2000 Feb; 136(2):248-50. PubMed ID: 10657834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetics: Newborn screening for sickle cell anemia.
    Meschino WS; Gibbons CA; Allanson J; Blaine SM; Cremin C; Dorman H; Honeywell C; Permaul J; Wilson BJ; Carroll JC
    Can Fam Physician; 2009 Oct; 55(10):1001. PubMed ID: 19826159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.